EUVIMEDAvasta EUVIMED
Crossref

Decreasing Bilirubin Serum Tests in Healthy Newborns During Birth Hospitalization

Sarah Sukkar, Gabriella Lorusso, Sara Jananeh, Robin Harrison, Mikki-Ann Martin, Evan Grabois, Marco Castillo Ayarza, Reeja Raj, Kathryn Cohen, Jayati Pal, Luis Garcia-Chacon, Liz Y Bayes

Pediatrics · 2023

DOI: 10.1542/peds.2022-059474 ↗

At a glance

Journal article in Pediatrics, 2023. Written by Sarah Sukkar and 11 co-authors. Institution: Holtz Children's Hospital at Jackson Memorial Hospital, Miami, Florida. Major MEDLINE topics: Jaundice, Neonatal. Cited 9 times so far (Crossref); 33 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

OBJECTIVES Substantial variability exists in hyperbilirubinemia screening and monitoring leading to unnecessary total serum bilirubin (TSB) testing in healthy newborns. We aimed to assess the impact of value-care interventions to decrease the monthly TSB testing rate per 100 patient-days among healthy newborns in our Mother-Baby Unit by 30% by June 2022. METHODS We formed a multidisciplinary team to review the current practice for ordering TSB among housestaff in our Mother-Baby Unit. We identified several themes: variation in clinical practice, fear of hyperbilirubinemia, and desire to act for high-intermediate risk bilirubin levels. The interventions consisted of obtaining faculty buy-in, redesigning the hyperbilirubinemia pathway, educating staff on high value-care, producing an instructional video, and prompting staff to incorporate a bilirubin risk assessment via smart phrases in our electronic health record. The primary outcome was the monthly TSB testing rate per 100 patient-days. Universal predischarge bilirubin screening, length of stay, phototherapy rates, and readmission rates were chosen as balancing measures. RESULTS The monthly rate of TSB testing was reduced from 51 to 26.3 TSB per 100 patient-days, representing a 48% reduction. This improvement was sustained for 12 months. The percentage of infants with at least 1 TSB measurement during birth hospitalization decreased from 48% to 30%. Predischarge bilirubin screening, length of stay, and readmission rates were unchanged. CONCLUSIONS Our quality improvement initiative led to a significant reduction in the monthly TSB testing per 100 patient-days in healthy newborns without evidence of harm.

Subjects

MeSH terms (MEDLINE)

Jaundice, NeonatalHumansInfant, NewbornBilirubinHospitalizationHyperbilirubinemiaNeonatal ScreeningPhototherapyRisk Assessment

Substances

Bilirubin

Authors and institutions

  • Holtz Children's Hospital at Jackson Memorial Hospital, Miami, Florida.
  • Department of Pediatrics, Section of Hospital Medicine.
  • Miller School of Medicine, University of Miami, Miami, Florida.

Cite

APA

Sukkar, S., Lorusso, G., Jananeh, S., Harrison, R., Martin, M. A., Grabois, E., Ayarza, M. C., Raj, R., Cohen, K., Pal, J., Garcia-Chacon, L., & Bayes, L. Y. (2023). Decreasing Bilirubin Serum Tests in Healthy Newborns During Birth Hospitalization. Pediatrics. https://doi.org/10.1542/peds.2022-059474

Vancouver

Sukkar S, Lorusso G, Jananeh S, Harrison R, Martin MA, Grabois E, et al. Decreasing Bilirubin Serum Tests in Healthy Newborns During Birth Hospitalization. Pediatrics. 2023. doi:10.1542/peds.2022-059474

BibTeX
@article{Sukkar2023,
  author = {Sukkar, Sarah and Lorusso, Gabriella and Jananeh, Sara and Harrison, Robin and Martin, Mikki-Ann and Grabois, Evan and Ayarza, Marco Castillo and Raj, Reeja and Cohen, Kathryn and Pal, Jayati and Garcia-Chacon, Luis and Bayes, Liz Y},
  title = {Decreasing Bilirubin Serum Tests in Healthy Newborns During Birth Hospitalization},
  journal = {Pediatrics},
  year = {2023},
  doi = {10.1542/peds.2022-059474}
}
Start for free →